How to buy Livongo Health (LVGO) shares in Australia

Livongo Health Inc is a medical devices business with stocks listed in the US. Livongo Health shares (LVGO) are listed on the NASDAQ and all prices are listed in US Dollars. Here's how to invest if you're based in Australia.

How to buy shares in Livongo Health

1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
3. Search for Livongo Health. Find the share by name or ticker symbol: LVGO. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Livongo Health reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Livongo Health, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Livongo Health. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Livongo Health stock price (NASDAQ:LVGO)

Use our graph to track the performance of LVGO stocks over time.

Livongo Health shares at a glance

• Key figures

Information last updated 2021-01-23.

52-week range	US$134.71 - US$147.84
50-day moving average	US$141.7294
200-day moving average	US$109.5777
Target price	US$122.13
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	US$-2.95

Where to buy Livongo Health stock

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Livongo Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Livongo Health share growth calculator

Investment amount

US$

Investment period Choose a point in time from the list1 week ago1 month ago3 months ago6 months ago1 year ago2 years ago3 years ago5 years ago

Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.

Is Livongo Health under- or over-valued?

Valuing Livongo Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Livongo Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Livongo Health's PEG ratio

Livongo Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.9675. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Livongo Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Livongo Health financials

Revenue TTM	US$317.2 million
Gross profit TTM	US$124 million
Return on assets TTM	-1.13%
Return on equity TTM	0%
Profit margin	-13.07%
Book value	5.308
Market capitalisation	US$14.2 billion

TTM: trailing 12 months

Shorting Livongo Health shares

There are currently 8.2 million Livongo Health shares held short by investors – that's known as Livongo Health's "short interest". This figure is 17.8% down from 10.0 million last month.

There are a few different ways that this level of interest in shorting Livongo Health shares can be evaluated.

Livongo Health's "short interest ratio" (SIR)

Livongo Health's "short interest ratio" (SIR) is the quantity of Livongo Health shares currently shorted divided by the average quantity of Livongo Health shares traded daily (recently around 1.9 million). Livongo Health's SIR currently stands at 4.27. In other words for every 100,000 Livongo Health shares traded daily on the market, roughly 4270 shares are currently held short.

However Livongo Health's short interest can also be evaluated against the total number of Livongo Health shares, or, against the total number of tradable Livongo Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Livongo Health's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Livongo Health shares in existence, roughly 80 shares are currently held short) or 0.1807% of the tradable shares (for every 100,000 tradable Livongo Health shares, roughly 181 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Livongo Health.

Find out more about how you can short Livongo Health stock.

Livongo Health share dividends

We're not expecting Livongo Health to pay a dividend over the next 12 months.

Livongo Health overview

Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. Its solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications. Its products include Livongo for diabetes, Livongo for hypertension, Livongo for prediabetes and weight management, and Livongo for behavioral health by myStrength. The company was formerly known as EosHealth, Inc. and changed its name to Livongo Health, Inc. in 2014. Livongo Health, Inc. was incorporated in 2008 and is headquartered in Mountain View, California. As of October 30, 2020, Livongo Health, Inc. operates as a subsidiary of Teladoc Health, Inc.

Frequently asked questions

• What percentage of Livongo Health is owned by insiders or institutions?

  Currently 8.498% of Livongo Health shares are held by insiders and 73.477% by institutions.

• When does the fiscal year end for Livongo Health?

  Livongo Health's fiscal year ends in December.

• Where is Livongo Health based?

  Livongo Health's address is: 150 West Evelyn Avenue, Mountain View, CA, United States, 94041

• What is Livongo Health's ISIN number?

  Livongo Health's international securities identification number is: US5391831030

• What is Livongo Health's CUSIP number?

  Livongo Health's Committee on Uniform Securities Identification Procedures number is: 539183103